HORIBA Medical launches next-generation HELO fully automated modular hematology solution
HORIBA Evolutive Laboratory Organisation (HELO) 2.0 embeds advanced hematology technologies to offer flexible, high-throughput, high-quality analytical performance
10 Jan 2024
HORIBA Medical has launched the new, CE-IVDR approved, HELO 2.0 high-throughput automated hematology platform. HELO 2.0 offers a flexible and efficient modular hematology solution that is fully scalable with many possible configurations for mid- to large-scale laboratories. Following the success of its previous HELO, this new-generation, high-end hematology range has been designed in consultation with customers to further improve and cover all needs of high-throughput fully automated hematology.
Advanced technologies embedded in the platform's Yumizen H2500 and Yumizen H1500 hematology analyzers ensure high-quality analytical performance. This includes 360-degree sample mixing without any premixing required. In addition, HELO 2.0’s data, tube management, waste, blood smear and digitalization management capability, addresses all pre-, post- and analytical needs, whilst also optimizing turnaround time (TAT), floor space and reagent storage. HELO 2.0 includes HORIBA Medical's accreditation assistance program which has been developed in accordance with ISO-15189 certification.
HELO 2.0 offers three standard configurations which can be applied in single lab or multi-site situations – standalone or combined with a tracking system. Using a track-based system which can be loaded continuously from multiple points, as well as new automatic quality control transfer, has improved sample workflow management to optimize efficiency. The HELO system automatically distributes sample and quality control tubes to the appropriate analyzer, and undertakes blood smears using reflex rules. Up to six analyzers and six slide preparation systems can be used on one track, with over 200 preloaded rules available in the hematology expert validation station.
The HELO 2.0 has recently received the 2023 Medical Device Network Excellence Award in the Environmental category. This is in recognition for its eco-friendly design which helps to reduce environmental impact. For example, the Yumizen H2500 requires only six reagents compared to an industry standard of 8–15 which not only reduces reagent use, but waste, toxicity and packaging.